FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 175 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,260,000 | -7.4% | 79,670 | +0.6% | 0.07% | -10.7% |
| Q1 2018 | $1,361,000 | +5.3% | 79,222 | +34.3% | 0.08% | +5.6% |
| Q4 2017 | $1,293,000 | -51.3% | 59,002 | -9.1% | 0.07% | -53.3% |
| Q3 2017 | $2,655,000 | +35.0% | 64,896 | -0.6% | 0.15% | +29.9% |
| Q2 2017 | $1,966,000 | -15.5% | 65,295 | +1.5% | 0.12% | -21.5% |
| Q1 2017 | $2,326,000 | -28.2% | 64,340 | -0.4% | 0.15% | -30.0% |
| Q4 2016 | $3,238,000 | -3.4% | 64,615 | +1.2% | 0.21% | -0.9% |
| Q3 2016 | $3,352,000 | +29.8% | 63,864 | +2.3% | 0.22% | +26.5% |
| Q2 2016 | $2,582,000 | – | 62,445 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|